Unmanned

Robots Journal

Subscribe to Robots Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Robots Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Robots Journal Authors: Automic Blog, Kevin Benedict, Julia Chernykh, Nicole Austin

Related Topics: Datacenter Automation, Biotech News Journal, Market Research, The Social Media Guide, Robots Journal

News Feed Item

Future US Hemostasis Market Outlook

NEW YORK, March 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future US Hemostasis Market Outlook

http://www.reportlinker.com/p0787969/Future-US-Hemostasis-Market-Outlook...

Complete report $8,500.  DataPack (test volumes, sales forecasts, supplier shares) $3,400.

Report Highlights

  • Comprehensive 424-page analysis of the US hemostasis market.
  • Major issues pertaining to the US hemostasis laboratory practice, as well as key  economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Ten-year volume and sales forecasts for 40 hemostasis procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
  • Placement estimates for major automated and semi-automated systems. 
  • Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
  • Ten-year reagent and instrument sales forecasts.
  • Sales and market shares of  leading reagent and instrument suppliers.
  • Review of hemostasis technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of  major current and emerging suppliers, including their sales, market shares, product portfolios,  marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contains 424 pages and 18 tables                                                                   

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Routine and Special Hemostasis Tests

1. Introduction

2. Activated Partial Thromboplastin Time (APTT)

3. Alpha-2 Antiplasmin

4. Antithrombin III

5. Bleeding Time

6. D-Dimer

7. Ethanol Flocculation Test

8. Euglobulin Lysis

9. Factor Assays

a. Introduction

b. Factor II

c. Factor V/Factor V Leiden

d. Factor VII

e. Factor VIII

f. Factor IX

g. Factor IXa

h. Factor X (Stuart Factor)

i. Factor Xa

j. Factor XI

k. Factor XII

l. Factor XIII

10. Fibrin Degradation Products

11. Fibrinogen

12. Heparin

13. Hirudin

14. Hypercoagulability and Thrombosis

15. Lipoprotein a

16. Plasmin

17. Plasminogen

18. Plasminogen Activator Inhibitor (PAI)

19. Platelet Function TestsTable of Contents (continued)

20. Platelet Aggregation

21. Proteins C and S

22. Prothrombin Fragment 1.2

23. Prothrombin Time (PT)

24. Reptilase Time

25. Thrombin Time

26. Tissue-Type Plasminogen Activator (t-PA)

27. Von Willebrand's Factor

B. Instrumentation Review

- Introduction

- Benk Hemolab

- Benk TRT Thrombotimer

- Bio/Data MCA 310

- Bio/Data MCA 210

- Bio/Data PAP-4C D/4D/4C

- Cardiovascular Diagnostics COAG

- Diagnostica Stago STA Compact

- Diagnostica Stago STA-R

- Diagnostica Stago Star 4/8

- Helena Laboratories Cascade 480

- Helena Laboratories Cascade M

- Helena Laboratories PACKS-4

- Helena THOR

- Instrumentation Laboratory ACL 100 and 1000 series

- Instrumentation Laboratory ACL6000

- Instrumentation Laboratory ACL7000

- Instrumentation Laboratory ACL9000

- Instrumentation Laboratory Electra 1000C

- Instrumentation Laboratory Electra 1400C

- Instrumentation Laboratory Electra 1600/C

- Instrumentation Laboratory Electra 1800C

- Instrumentation Laboratory Futura

- ITC Hemochron 8000

- Roche Diagnostics CoaguChek

- Siemens BCS

- Siemens BCT

- Siemens BF II/Fibrintimer Series

- Sysmex CA-50

- Sysmex CA-500

- Sysmex CA-1500Table of Contents (continued)

- Sysmex CA-5000/CA-1000

- Sysmex CA-6000

- Sysmex CA-7000

- Teco Coatron II/Jr./AccuStasis 5000

- Trinity Biotech Amax CS190

- Trinity Biotech Amax CS400

- Trinity Biotech Coag-A-Mate Max

- Trinity Biotech KC 40, 4A, 1A Series

- Trinity Biotech MDA 180

- Trinity Biotech Coag-A-Mate MTX

- Trinity Biotech Coag-A-Mate RA4

- Trinity Biotech Coag-A-Mate XC/Plus

- Trinity Biotech Coag-A-Mate XM

C. Major in Vitro Diagnostic Technologies and Their

Potential Applications

1. Chromogenic Substrates

2. Monoclonal and Polyclonal Antibodies

3. Immunoassays

a. Applications

b. Technological Principle

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- EMIT

- Dot Immunobinding Assays

- Capillary Immunoassays

- Enzyme Amplification

- Electrochemical Immunoassay

d. Fluorescent Immunoassays

- Fluorescence Polarization

- Time-Resolved Pulse Fluorescence

- Fluorescence Lifetime

e. Latex Agglutination

f. Immunoprecipitation

4. Microcomputers

5. Automation

6. Robotics

7. DNA Probes

a. Overview

b. Amplification Methods Table of Contents (continued)

- PCR

- Ligase Chain Reaction

- Branched DNA

- Q-Beta Replicase

- NASBA

- SDA

- 3 SR

- HPA

- Two-Tiered System

- LAT

8. Artificial Intelligence

9. Dry Chemistry

10. Biosensors

D. Worldwide Market Overview

1. Business Environment

2. Market Structure

3. Market Size and Growth

4. POC Testing Market

USA

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Industry Consolidation

4. Managed Care

5. Hospitals

6. Admissions

7. Length of Stay

8. Industry Diversification

9. Physician Demographics

10. Population Aging

a. Chronic Illnesses

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

11. Laboratory RegulationsTable of Contents (continued)

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial laboratories

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point-of-Care Testing

c. Home/Self Testing

d. Other Decentralized Testing Locations

D. Market Size, Growth And Major Suppliers

Major Product Development Opportunities

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market ChallengesTable of Contents (continued)

Competitive Assessments

- Abbott

- American Diagnostica

- Avocet Medical

- Axis-Shield

- Beckman Coulter

- Becton Dickinson

- Bio/Data Corporation

- Biosite

- Chrono-Log

- Corgenix Medical

- Diagnostica Stago

- Helena Laboratories

- HYPEN BioMed

- Instrumentation Laboratory

- ITC

- Nanogen

- Roche

- Siemens

- Sienco

- Sysmex

- Thermo Fischer

- Trinity Biotech

- ZyCareList of Tables

Major Companies Developing or Marketing Activated Clotting Time Tests

Major Companies Developing or Marketing APTT Tests

Major Companies Developing or Marketing Alpha-2 Antiplasmin

Tests

Major Companies Developing or Marketing Antithrombin III Tests

Major Companies Developing or Marketing Bleeding Time Tests

Major Companies Developing or Marketing D-dimer Tests

Major Companies Developing or Marketing Factor Assays

Major Companies Developing or Marketing Fibrin Degradation

Product Tests

Major Companies Developing or Marketing Fibrinogen Tests

Major Companies Developing or Marketing Heparin Tests

Major Companies Developing or Marketing Plasmin Tests

Major Companies Developing or Marketing Plasminogen Tests

Major Companies Developing or Marketing Plasminogen Activator

Inhibitor Tests

Major Companies Developing or Marketing Platelet Aggregation

Tests

Major Companies Developing or Marketing Protein C Tests

Major Companies Developing or Marketing Protein S TestsList of Tables (continued)

Major Companies Developing or Marketing PT Tests

Major Companies Developing or Marketing Thrombin Time Tests

Major Companies Developing or Marketing TPA Tests

Major Companies Developing or Marketing Von Willebrand's

Factor Tests

Worldwide, All Market Segments, Laboratories Performing

Hemostasis Tests By Country, 2010

Worldwide, All Market Segments, Total Hemostasis Test Volume

By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Reagent

Market By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Instrument

Market By Country, 2010-2020

Worldwide, All Market Segments, Total Hemostasis Diagnostics

Market By Country, 2010-2020

Executive Summary Table: U.S.A., Total Hemostasis Diagnostics

Market By Market Segment and Product Category, 2010-2020

U.S.A., Laboratories Performing Hemostasis Tests By Market

Segment, 2010

U.S.A., Hospital Laboratories Performing Hemostasis Tests By

Bed Size, 2010

U.S.A., Commercial/Private Laboratories Performing Hemostasis

Tests By Annual Test Volume, 2010

U.S.A., Physician Offices/Group Practices Performing Hemostasis

Tests By Practice Size, 2010List of Tables (continued)

U.S.A., Hospital Laboratories Average Daily Test Volume, 2010

U.S.A., Commercial/Private Laboratories Average Daily Test

Volume, 2010

U.S.A., Physician Offices/Group Practices Average Daily Test

Volume

U.S.A., Total Hemostasis Test Volume By Market Segment,

2010-2020

U.S.A., All Market Segments Hemostasis Test Volume, 2010-2020

U.S.A., Hospital Laboratories Hemostasis Test Volume, 2010-2020

U.S.A., Physician Offices/Group Practices Hemostasis Test Volume,

2010-2020

U.S.A., Commercial/Private Laboratories Hemostasis Test Volume,

2010-2020http://www.reportlinker.com Reagent Market By Market Segment,

2010-2020

U.S.A., Major Suppliers of Hemostasis Reagents Estimated

Sales and Market Shares, 2010

U.S.A., Hemostasis Instrument Market By Market Segment,

2010-2020

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Total Instrument Placements and Market Shares, 2010

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Placements and Installed Base By Supplier and Model, 2010List of Tables (continued)

U.S.A., Major Suppliers of Hemostasis Analyzers, Estimated

Instrument Sales and Market Shares, 2010

U.S.A., Total Hemostasis Diagnostics Market By Product

Category, 2010-2020

U.S.A., Major Suppliers of Hemostasis Diagnostic Products,

Estimated Sales and Market Shares, 2010

To order this report:

In Vitro Diagnostic Industry: Future US Hemostasis Market Outlook

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.